Inhibition of Salivary ALPHA-Amylase by a Bistorta major (S. F. Gray) Extract as a Therapeutic Strategy for the Treatment of Diabetes Mellitus
ISEF · 2025 Translational Medical Science
Overview
Diabetes mellitus (DM) is a very common disease affecting millions of people worldwide. In light of its widespread prevalence, researchers are looking for therapeutic targets they can influence in order to improve the patient's condition. Salivary a-amylase (SAA) plays an important role in carbohydrate metabolism, as it breaks down polysaccharides into oligosaccharides, that can get further hydrolyzed and absorbed into the bloodstream, which leads to postprandial hyperglycemia. Acarbose, a a-glucosidase inhibitor (AGI), though effective, often causes undesirable gastrointestinal side effects. This is why it is of great importance for researchers to identify natural alternatives. This project investigates the potential of Bistorta major (S. F. Gray) rhizome hydroalcoholic extracts as natural SAA inhibitors. Hydroalcoholic extracts of B. major rhizomes demonstrated significant inhibitory activity against SAA, with an IC50 value of 148 µg/mL, suggesting moderate inhibition that balances efficacy and safety. For the development of this project we got delivered medicinal plants, determined moisture content in fresh herbs, prepared aqueous and hydroalcoholic herbal extracts, performed partial phytochemical characterization of the obtained extracts, determined in vitro inhibitory activity of the extracts on human SAA and finally we performed a LC-ESI-MS/MS analysis of phenolic compounds. Further research, including in vivo studies and structural docking analysis, is recommended to elucidate the molecular interactions and optimize the therapeutic potential of B. major extracts. This research underscores the importance of exploring traditional medicinal plants for developing novel antidiabetic therapies.
Competition history
- ISEF 2025
Resources
Related projects
ISEF · 2022
1,4-Benzodioxin Derivatives as Dual Inhibitors for Alpha-amylase and Alpha-glucosidase for Managing Type 2 Diabetes
ISEF · 2018
Garcinia binucao Fruit and Leaf: Phytochemicals-Mediated Antioxidant, Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibitors
ISEF · 2022
Enzyme Inhibition: Combating Cardiovascular Diseases, Diabetes, and Obesity Using Phytochemicals Found in Indian Spices
ISEF · 2026
Discovering a Path from Molecular Modeling to Alzheimer's Phytotherapeutics: Characterizing Novel GSK3ß Inhibitors in silico and in vitro
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair